Nuvei Corp
F:62E
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nuvei Corp
F:62E
|
CA |
|
S
|
Snam SpA
XHAM:SNM
|
IT |
|
Spartan Delta Corp
F:4YJ0
|
CA |
|
I
|
ImmunoGen Inc
F:IMU
|
US |
|
T
|
Telekom Austria AG
XMUN:TA1
|
AT |
|
Space Exploration Technologies Corp
F:SPX
|
US |
|
A
|
Anglo American Platinum Ltd
XMUN:RPHA
|
ZA |
|
I
|
ImmunoGen Inc
XMUN:IMU
|
US |
|
E
|
EMX Royalty Corp
XMUN:6E9
|
CA |
|
C
|
Conocophillips
XMUN:YCP
|
US |
|
S
|
Stockland Corporation Ltd
F:LN1
|
AU |
|
JetBlue Airways Corp
NASDAQ:JBLU
|
US |
|
A
|
Advanced Micro Devices Inc
DUS:AMD
|
US |
|
B
|
BHP Group Ltd
XMUN:BHP1
|
AU |
|
W
|
Wharf Holdings Ltd
XMUN:WHA
|
HK |
|
L
|
Lululemon Athletica Inc
F:33L
|
CA |
|
C
|
Commerzbank AG
DUS:CBK
|
DE |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 62E's stock price target?
Not Available
62E does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Nuvei Corp?
Projected CAGR
17%
Over the last 5 years, the compound annual growth rate for Revenue has been 51%. The projected CAGR for the next 3 years is 17%.
What is the Operating Income forecast for Nuvei Corp?
Projected CAGR
37%
Over the last 5 years, the compound annual growth rate for Operating Income has been 103%. The projected CAGR for the next 3 years is 37%.